IRIS UniCatt

Tumbarello, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.999
EU - Europa 10.774
AS - Asia 9.282
SA - Sud America 1.719
Continente sconosciuto - Info sul continente non disponibili 344
AF - Africa 248
OC - Oceania 22
AN - Antartide 1
Totale 37.389
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.594
DE - Germania 4.215
SG - Singapore 3.888
CN - Cina 2.932
BR - Brasile 1.345
SE - Svezia 1.272
IT - Italia 1.221
UA - Ucraina 847
FR - Francia 841
VN - Vietnam 652
PL - Polonia 559
GB - Regno Unito 487
IE - Irlanda 378
IN - India 306
FI - Finlandia 276
TR - Turchia 273
ID - Indonesia 270
RU - Federazione Russa 215
BD - Bangladesh 191
HK - Hong Kong 176
CA - Canada 172
JP - Giappone 148
AR - Argentina 129
MX - Messico 119
NL - Olanda 84
IQ - Iraq 78
ZA - Sudafrica 71
EC - Ecuador 61
CO - Colombia 58
ES - Italia 58
BE - Belgio 57
AT - Austria 56
VE - Venezuela 46
MA - Marocco 43
SA - Arabia Saudita 42
PK - Pakistan 35
IR - Iran 26
PH - Filippine 26
JM - Giamaica 25
UZ - Uzbekistan 25
CH - Svizzera 24
IL - Israele 24
RO - Romania 24
KR - Corea 21
TN - Tunisia 21
AE - Emirati Arabi Uniti 20
EG - Egitto 19
JO - Giordania 19
LT - Lituania 19
UY - Uruguay 19
CL - Cile 18
MY - Malesia 18
CR - Costa Rica 17
KE - Kenya 17
AU - Australia 16
HN - Honduras 16
PE - Perù 16
BG - Bulgaria 15
CZ - Repubblica Ceca 15
BO - Bolivia 14
GR - Grecia 14
HU - Ungheria 13
KZ - Kazakistan 13
CI - Costa d'Avorio 12
EU - Europa 12
NP - Nepal 12
DZ - Algeria 11
ET - Etiopia 11
PT - Portogallo 11
PY - Paraguay 10
TH - Thailandia 10
AL - Albania 9
LY - Libia 9
OM - Oman 9
AZ - Azerbaigian 8
LV - Lettonia 8
TT - Trinidad e Tobago 8
BZ - Belize 7
GT - Guatemala 7
HR - Croazia 7
NI - Nicaragua 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
MD - Moldavia 6
NG - Nigeria 6
RS - Serbia 6
BH - Bahrain 5
EE - Estonia 5
KG - Kirghizistan 5
LB - Libano 5
LK - Sri Lanka 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
VA - Santa Sede (Città del Vaticano) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BA - Bosnia-Erzegovina 4
BS - Bahamas 4
MN - Mongolia 4
MU - Mauritius 4
Totale 36.972
Salva come PNG Salva come JPEG
Città #
Singapore 2.023
Ashburn 1.572
Chandler 1.522
San Jose 1.288
Hangzhou 626
Jacksonville 593
Beijing 437
Warsaw 437
San Mateo 399
Nanjing 376
Dublin 371
Ann Arbor 361
Dearborn 302
New York 289
Woodbridge 270
Wilmington 269
Nürnberg 266
Los Angeles 259
Jakarta 236
Ho Chi Minh City 212
Izmir 207
Houston 204
Lauterbourg 202
Boston 182
Hanoi 168
Council Bluffs 163
Munich 163
Hefei 162
Hong Kong 160
Milan 158
The Dalles 152
Fairfield 146
Chicago 145
Lawrence 140
Seattle 140
Moscow 138
Frankfurt am Main 134
São Paulo 133
Tokyo 132
Rome 131
Nanchang 128
Cattolica 125
Marseille 121
Redwood City 106
Kraków 104
Dallas 103
Buffalo 97
Santa Clara 94
Princeton 81
Shenyang 73
Guangzhou 71
Kunming 70
Tianjin 67
Boardman 66
Bremen 66
Atlanta 62
Mountain View 62
Hebei 61
Lancaster 61
Helsinki 59
Phoenix 57
Brussels 56
Norwalk 56
St Louis 52
Brooklyn 51
Zhengzhou 51
London 48
Orem 47
University Park 47
Cambridge 43
Toronto 43
Montreal 42
Changsha 41
Jiaxing 41
Paris 41
Redmond 40
Rio de Janeiro 39
Shanghai 39
Kent 38
Falls Church 37
Da Nang 36
San Francisco 36
Baghdad 35
Nuremberg 34
Vienna 34
Johannesburg 33
Jinan 32
Philadelphia 32
Fremont 31
Pune 31
Belo Horizonte 28
Denver 28
Dhaka 28
Leawood 28
Chennai 27
Mexico City 27
Haiphong 26
Amsterdam 25
Brasília 25
Augusta 24
Totale 18.454
Salva come PNG Salva come JPEG
Nome #
Factors associated with mortality in bacteremic patients with haematologic malignancies 535
A prospective survey of febrile events in hematological malignancies 471
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 409
Factors associated with mortality in bacteremic patients with hematologic malignancies. 385
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 366
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 366
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 361
Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies 359
A prospective survey of febrile events in hematological malignancies 324
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 324
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 321
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 318
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 314
Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients 310
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 309
Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne: a Nine-Year Experience at a Large Italian Teaching Hospital 304
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 304
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 296
Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 291
Whole-genome sequencing reveals host factors underlying critical COVID-19 274
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 273
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 266
The role of carbapenem-resistant pathogens in cSSTI and how to manage them 261
Meropenem/ vaborbactam: a next generation β-lactam β-lactamase inhibitor combination 259
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 257
Optimized Use of the MALDI BioTyper System and FilmArray BCID Panel for the Direct Identification of Microbial Pathogens from Positive Blood Cultures 255
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 249
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 245
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 238
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 234
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 230
Factors associated with mortality in bacteremic patients with hematologic malignancies. 226
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 218
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 216
Attitudes and practices of dentists treating patients infected with human immunodeficiency virus in the era of highly active antiretroviral therapy 215
Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV infected subjects 210
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 209
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 204
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 204
Safety and effectiveness of transvenous lead extraction in octogenarians 202
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 202
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 201
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 201
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 200
Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections 199
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 197
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 195
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 193
Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital 192
Characterisation and risk-factor profiling of P. aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains 192
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in HIV-infected patients 189
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 188
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact 187
Neurological involvement during legionellosis, look beyond the lung 186
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 185
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome 184
Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome. 182
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection 181
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 181
Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators 179
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 178
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 177
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 177
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 176
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report 175
An explainable model of host genetic interactions linked to COVID-19 severity 173
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 173
Attitudes and practices of dentists treating HIV patients in HAART era. 171
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy 171
Mortality in patients with early- or late-onset candidaemia 170
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 169
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates 168
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 168
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 167
Neurological involvement during Legionellosis, look beyond the lung 166
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 166
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 166
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 165
Oral lesions in HIV and HCV co-infected individuals in HAART era 164
A prospective survey of febrile events in hematological malignancies 164
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 164
Molecular mechanisms, epidemiology, and clinical importance of β-lactam resistance in enterobacteriaceae 164
Dental care and HIV-infected individuals: are they equally treated? 163
Dental hygienists behaviour towards HIV-positive patients in highly active antiretroviral therapy era: a pilot survey 162
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 161
Multidrug-Resistant Proteus mirabilis Bloodstream Infections: Risk Factors and Outcomes 161
HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy 160
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 160
Bloodstream infections caused by extended -spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome 158
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 158
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 157
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 157
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 157
Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study 156
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 156
Correlation between cidofovir-associated uveitis and failing immunorestoration during HAART. 155
Oral lesions in HIV and HCV co-infected individuals in HAART era 154
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. 154
Evaluation of the New NucliSENS EasyQ KPC test for rapid detection of Klebsiella pneumoniae carbapenemase genes (blaKPC) 153
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 153
Totale 21.993
Salva come PNG Salva come JPEG
Categoria #
all - tutte 141.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 141.323
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.661 0 0 0 119 120 111 37 364 101 137 270 402
2022/20234.076 479 557 314 580 287 518 177 317 494 133 153 67
2023/20241.776 110 581 46 83 56 226 106 73 27 60 176 232
2024/20253.812 118 131 288 139 392 118 123 206 611 328 719 639
2025/202610.292 1.575 281 519 1.077 1.911 535 1.801 514 665 778 365 271
2026/20273.461 406 1.658 797 600 0 0 0 0 0 0 0 0
Totale 37.389